(Q71077355)
Statements
Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group (English)
1 April 1996
scientific article published on 01 April 1996